Updates in Management of SARS-CoV-2 Infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide from the beginning of 2020. The infection...
€104,74 EUR
€104,74 EUR
SKU: 9783036553894
Product Type: Books
Please hurry! Only 327 left in stock
Author: Robert Flisiak
Format: Hardcover
Language: English
Subtotal: €104,74
10 customers are viewing this product
Updates in Management of SARS-CoV-2 Infection by Flisiak, Robert

Updates in Management of SARS-CoV-2 Infection

€104,74

Updates in Management of SARS-CoV-2 Infection

€104,74
Author: Robert Flisiak
Format: Hardcover
Language: English

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide from the beginning of 2020. The infection is mostly asymptomatic but some patients may develop COVID-19 (coronavirus disease 2019) with a severe or critical course leading to pneumonia, acute respiratory distress syndrome, and multiorgan failure. Apart from the virus-related damage of the lungs, pathomechanism of the disease seems to be linked to thromboembolism and inflammation accompanied by overproduction of proinflammatory cytokines, termed a cytokine storm, responsible for multiorgan damage and death. Since the development of a new therapeutic molecule, dedicated strictly to a particular virus is time-consuming, physicians and scientists have started to test and repurpose old medications. Unfortunately, after one year of pandemics, there is still a lack of optimal therapy and no clear indicators of recovery. A major issue is also insufficient knowledge on predictors of the severe or deadly course of the disease, which could also help to switch from one therapeutic option to another. Due to many gaps still existing in the management of COVID-19, there is a need for the accumulation of new data particularly from real-world experience, which could be applicable to practice guidelines. The objective of this special issue of the Journal of Clinical Medicine is to provide an update on the mangement for the diagnostic workup and pharmacotherapy of SARS-CoV-2 infection.



Author: Robert Flisiak
Publisher: Mdpi AG
Published: 09/19/2022
Pages: 200
Binding Type: Hardcover
Weight: 1.40lbs
Size: 9.61h x 6.69w x 0.69d
ISBN: 9783036553894

This title is not returnable

Returns Policy

You may return most new, unopened items within 30 days of delivery for a full refund. We'll also pay the return shipping costs if the return is a result of our error (you received an incorrect or defective item, etc.).

You should expect to receive your refund within four weeks of giving your package to the return shipper, however, in many cases you will receive a refund more quickly. This time period includes the transit time for us to receive your return from the shipper (5 to 10 business days), the time it takes us to process your return once we receive it (3 to 5 business days), and the time it takes your bank to process our refund request (5 to 10 business days).

If you need to return an item, simply login to your account, view the order using the "Complete Orders" link under the My Account menu and click the Return Item(s) button. We'll notify you via e-mail of your refund once we've received and processed the returned item.

Shipping

We can ship to virtually any address in the world. Note that there are restrictions on some products, and some products cannot be shipped to international destinations.

When you place an order, we will estimate shipping and delivery dates for you based on the availability of your items and the shipping options you choose. Depending on the shipping provider you choose, shipping date estimates may appear on the shipping quotes page.

Please also note that the shipping rates for many items we sell are weight-based. The weight of any such item can be found on its detail page. To reflect the policies of the shipping companies we use, all weights will be rounded up to the next full pound.

Related Products

Recently Viewed Products